Arlington Trust’s Merck MRK Stock Holding History

Arlington Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Buy	1,750 +788	+82%	+$92.2K	0.02%	110
2026 Q1	$116K	Buy	962 +347	+56%	+$40.1K	0.01%	143
2025 Q4	$64.7K	Sell	615 -2,845	-82%	-$267K	0.01%	183
2025 Q3	$290K	Buy	3,460 +50	+1%	+$4.12K	0.05%	142
2025 Q2	$270K	Sell	3,410 -4,245	-55%	-$337K	0.05%	141
2025 Q1	$687K	Sell	7,655 -294	-4%	-$27.4K	0.15%	80
2024 Q4	$791K	Hold	7,949	–	–	0.17%	76
2024 Q3	$903K	Sell	7,949 -219	-3%	-$26K	0.2%	65
2024 Q2	$1.01M	Buy	8,168 +520	+7%	+$67K	0.24%	58
2024 Q1	$1.01M	Sell	7,648 -228	-3%	-$28.1K	0.26%	56
2023 Q4	$859K	Buy	7,876 +3,858	+96%	+$400K	0.24%	60
2023 Q3	$414K	Buy	+4,018	New	+$433K	0.17%	64

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Arlington Trust's MRK Position: Q2 2026 in Review

Arlington Trust increased its Merck (MRK) stake by 82% in Q2 2026, buying an estimated $92.2K and bringing the position to 1,750 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #110.

Arlington Trust first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.01M in Q2 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Arlington Trust held 1,750 shares of Merck worth $225K as of Q2 2026.
Arlington Trust bought 788 Merck shares in Q2 2026, an estimated $92.2K.
Merck made up 0.02% of Arlington Trust's portfolio in Q2 2026, its #110 holding.
Arlington Trust first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
Arlington Trust's Merck position peaked at $1.01M in Q2 2024.
1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.